<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.15828.004</object-id><label>Table 1.</label><caption><title>In vitro properties of GCD-0810.</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Compound</th><th colspan="2">ER binding<sup>&#8727;</sup></th><th colspan="2">Transcription<sup>&#8224;</sup></th><th colspan="2">Cell viability<sup>&#8225;</sup></th><th colspan="2">ER&#945; degradation<sup>&#167;</sup></th></tr><tr><th>ER&#945;</th><th>ER&#946;</th><th colspan="2">3X ERE~LUC</th><th colspan="2">CellTiter-Glo</th><th colspan="2">In-Cell Western</th></tr><tr><th colspan="2">K<sub>i</sub> [nM]</th><th>IC<sub>50</sub> <break/>[nM]</th><th>E<sub>max</sub> <break/>[% E2]</th><th>IC<sub>50</sub> <break/>[nM]</th><th>E<sub>max</sub> <break/>[% E2]</th><th>EC<sub>50</sub> <break/>[nM]</th><th>E<sub>max</sub> <break/>[% Veh.]</th></tr></thead><tbody><tr><td>GDC-0810</td><td>3.8 &#177; 1.6</td><td>3.7 &#177; 4.0</td><td>1.3 &#177; 0.8</td><td>6.1 &#177; 2.8</td><td>2.5 &#177; 2.1</td><td>24.6 &#177; 3.3</td><td>0.65 &#177; 0.50</td><td>15.3 &#177; 3.4</td></tr><tr><td>4-OH Tam</td><td>2.2 &#177; 1.3</td><td>3.6 &#177; 1.7</td><td>6.7 &#177; 3.6</td><td>4.7 &#177; 2.9</td><td>0.53 &#177; 0.25</td><td>48.0 &#177; 4.7</td><td>0.14 &#177; 0.04</td><td>51.9 &#177; 2.7<sup>#</sup></td></tr><tr><td>Fulvestrant</td><td>13.1 &#177; 10.8</td><td>13.2 &#177; 7.6</td><td>0.3 &#177; 0.2</td><td>4.1 &#177; 2.6</td><td>0.56 &#177; 0.70</td><td>25.4 &#177; 3.7</td><td>0.39 &#177; 0.18</td><td>6.4 &#177; 2.0</td></tr></tbody></table><table-wrap-foot><fn><p><sup>&#8727;</sup>&#160;Binding affinities (Ki) of GDC-0810, 4-hydroxytamoxifen (4-OHT), and fulvestrant for ER&#945; and ER&#946;. Shown are the mean and standard deviation of 3&#8211;4 experiments run in duplicate.</p><p><sup>&#8224;</sup> ER&#945; antagonist reporter assay. Results are the mean and standard deviation of 3 experiments.</p></fn><fn><p><sup>&#8225;</sup>&#160;Relative cell viability after 5 d incubation with compound. Shown are the mean and standard deviation of more than 50 assays run in triplicate.</p><p><sup>&#167;</sup>&#160;Relative ER&#945; immunofluorescence activity in MCF7 In-Cell Western.</p></fn><fn><p><sup>#</sup>&#160;The apparent reduction in ER&#945; immunoreactivity is not reproduced in western blots.</p></fn></table-wrap-foot></table-wrap>